Cytosine deaminase (CD) catalyzes the deamination of cytosine to uracil and that of 5-methylcytosine to thymine (Fig. 1) . The antimetabolite 5-fluorouracil (5-FU) is one of the most active chemotherapeutic agents for cancer treatment, but it has limited efficacy due to gastrointestinal and hematological toxicities. Due to its ability to convert nontoxic 5-fluorocytosine (5-FC) into 5-FU and its absence in mammalian cells, the combination of 5-FC with CD in enzyme-prodrug gene therapy has been shown to effectively control tumor growth and is currently being evaluated in clinical trials. Here we have determined the yeast CD structure at 1.6 Å resolution at beamlines BL12B2 and BL41XU [1, 2] .
. Proposed catalytic mechanism for yeast CD. superfamily, whereas the 158-residue dimeric yeast counterpart is grouped into the CDA superfamily [3] . The active site of yeast CD contains one tightly bound zinc ion, which is tetrahedrally coordinated by His 62 , Cys 91 , Cys 94 , and a bound inhibitor (Fig. 3) . The complex structure reveals that yeast CD converts the inhibitor 2-hydroxypyrimidine into 4-(R)hydroxyl-3,4-dihydropyrimidine, which is enantiomeric to the configuration observed in E. coli CD. Therefore, the crystal structures of bacterial and fungal CDs provide an excellent example of convergent evolution, in that they have evolved from unrelated ancestral proteins but have achieved the same deamination reaction. The protein structure is composed of a central five-stranded β -sheet (β1-β5) sandwiched by six α-helices (αA -αF) ( Fig. 2(a) ). Surprisingly, even though yeast CD shares a higher sequence identity to cytidine deaminases (CDAs), its closest structural match is the subdomain 2 of the AICAR transformylase domain, due to the common αD helix and the same direction of the β5 strand ( Fig. 2(b) ). The strong conservation of tertiary structures suggests that these enzymes are descendants of a single ancestral gene, and thereby define a new superfamily.
Interestingly, the 426-residue hexameric E. coli CD belongs to Based on structural studies, we propose a deamination mechanism for yeast CD (Fig. 1) . The substrate binds to an active site and induces a closed conformation to sequester the reaction from the solvent. The water molecule activated by the zinc ion attacks the C 4 atom with the assistance of Glu 64 serving as a proton shuttle. The product uracil moves toward the zinc ion for ligation and this would weaken its interaction with the C-terminal tail, allowing its release from the active site. The active site architectures of yeast CD and CDAs are strikingly similar. However, they contain unique substraterecognition residues, in particular, C-terminal tails. The presence of an αD helix in yeast CD leads strands β4 and β5 to be parallel and this results in the C-terminal tail moving back sharply t o w a r d s t h e a c t i v e si t e t o accommodate only the cytosine base within the same molecule (Fig. 4(a) ). On the other hand, the lack of an αD helix in B. subtilis CDA leads strands β4 and β 5 to be antiparallel and this results in an o p p o s i t e d i r e c t i o n f o r t h e Cterminal tail, which enlarges the active site of the adjacent molecule to accommodate a larger cytidine substrate (Fig. 4(b) ). P r e v i o u s s t u d i e s h a v e demonstrated that yeast CD has a greater therapeutic potential than t h e b a c t e r i a l e n z y m e s i n t h e enzyme-prodrug strategy. The C 5 atom of the pyrimidine ring is adjacent to a hydrophobic cluster and faces toward Phe 114 , with a distance of 4.1 Å. When a fluorine atom is attached to an aromatic ring, it will make it very hydrophobic. Therefore, the hydrophobic cluster in yeast CD should enhance the binding of 5 -FC. On the other hand, the C 5 atom faces toward A s p 3 1 4 i n E . c o l i C D , w i t h a distance of 3.6 Å between C 5 and Asp314 O δ 1 . Close contact with such a polar residue would be u n f a v o r a b l e t o 5 -F C b i n d i n g . These structural observations are consistent with enzyme kinetic measurements.
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